KAMADA Price to Book

<div class='circular--portrait' style='background:#008000;color: #f8f8f8;font-size:3em;padding-top: 38px;;'>KMD</div>
KMDA -- Israel Stock  

ILA 2,859  236.00  9.00%

KAMADA price to book fundamental analysis lookup allows you to check this and other indicators for KAMADA or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Price to Book

 
Refresh

KAMADA Price to Book Analysis

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

  Cash and Equivalents

P/B 
 = 
MV Per Share 
BV Per Share 
More About Price to Book | All Equity Analysis

Current KAMADA Price to Book

792.72 

KAMADA Distress Driver Correlations

About Price to Book

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.Compare to competition

  Net Income

Based on latest financial disclosure the price to book indicator of KAMADA is roughly 792 times. This is 2986.92% higher than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?Specialty & Generic industry, The Price to Book for all stocks is 8235.65% lower than the firm.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

KAMADACurrent Valuation Drivers

2014201520162017201820192020 (projected)
Revenue Per Employee235.31 K219.14 K204.99 K248.97 K280.56 K296.47 K257.28 K
PPandE Turnover3.293.253.554.344.565.134.36
Receivables Turnover3.433.113.33.823.74.614.72
Inventory Turnover2.082.372.092.153.032.92.14
Operating Margin(16.152818)(16.341945)(7.072806)7.2416.8217.9122.8
Return on Investment(11.828228)(14.226296)(7.762686)9.3118.7817.8919.3
Cash Flow Per Share(0.275588)(0.383841)0.0520480.0896110.2617190.68320.7372
Revenue to Assets0.59650.68540.77730.84210.82880.73180.6884
Quick Ratio2.322.331.852.553.413.032.64
Asset Turnover0.54980.63230.76640.92720.87980.81550.7461
Current Ratio3.143.512.833.34.74.396.14
Debt to Equity Ratio0.0931640.0025930.026610.022170.0113730.042474.6
EBITDA Margin(11.482446)(10.529854)(2.157586)10.421.020.8722.52
Gross Margin21.1722.627.9431.2136.2339.1132.87
Profit Margin(18.592838)(16.121649)(8.688415)6.7119.4817.490.0019
Sales per Share1.981.932.122.712.843.152.62
Inventories25.42 M26.34 M25.59 M21.07 M29.32 M43.17 M46.58 M
Receivables19.87 M25.08 M21.79 M31.97 M29.9 M25.24 M22.64 M
Accounts Payable20.57 M20.98 M21.89 M23.86 M22.55 M30.64 M25.02 M
Total Assets119.14 M101.99 M99.7 M122.11 M138.12 M173.8 M107 M
Current Assets97.19 M80.59 M77.08 M96.88 M110.89 M143.56 M85 M
Cash and Equivalents14.55 M5.05 M9.97 M12.68 M18.09 M42.66 M66.83 M
Shareholders Equity80.42 M72.51 M66.74 M89.49 M112.38 M135.32 M146 M

KAMADA Fundamentals

About KAMADA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze KAMADA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KAMADA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KAMADA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Stocks Correlation. Please also try CEO Directory module to screen ceos from public companies around the world.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page